Assessing the metabolic impact of aripiprazole versus risperidone in the treatment of schizophrenia: a randomized double-blind controlled clinical trial. [PDF]
BMC PsychiatryRahimi Darehbagh R +2 more
europepmc +1 more source
Aripiprazole for treatment of attenuated psychosis syndrome in an adolescent with 22q11.21 deletion syndrome: A case report. [PDF]
Medicine (Baltimore)Algarzae NK +6 more
europepmc +1 more source
Managing Bipolar Disorder With Aripiprazole Once Monthly: From Symptom Stabilization to Functional Recovery. [PDF]
Psychiatry InvestigYang HR +6 more
europepmc +1 more source
Combining Three Long-acting Injectable Antipsychotics: A Case Series. [PDF]
Clin Psychopharmacol Neurosciİnci Kenar AN, Balki Tekin S.
europepmc +1 more source
A prospective year-long follow-up of lurasidone use in clinical practice:factors predicting treatment persistence [PDF]
, 2018 Mace, Shubhra +2 more
core +2 more sources
Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review. [PDF]
Neuropsychopharmacol RepAbavana V, Sadiq S.
europepmc +1 more source
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor. [PDF]
Int J NeuropsychopharmacolÅgren R, Sahlholm K.
europepmc +1 more source
Gender transition and intellectual developmental disorders: a case report. [PDF]
Sex MedSoldati L +3 more
europepmc +1 more source
The effect of early initiation of aripiprazole once-monthly 400 mg on health care resource utilization and health care costs in patients diagnosed with bipolar I disorder: Real-world evidence from US claims data. [PDF]
J Manag Care Spec PharmAwasthi S +3 more
europepmc +1 more source
Rational antipsychotic polypharmacy in psychotic and bipolar disorders: A focus on D2 receptor partial agonists. [PDF]
Ment Health ClinSalwan A.
europepmc +1 more source